A phase I trial of accelerated intermittent theta burst rTMS for amnestic MCIStephanie Aghamoosa, James Lopez, Katrina Rbeiz, Holly H Fleischmann, Olivia Horn, Katrina Madden, Kevin A Caulfield, Michael U Antonucci, Gonzalo Revuelta, Lisa M McTeague, Andreana Benitez
6 May 2024
Does stereotactic thrombolysis with alteplase for intracerebral haemorrhage alter intraventricular haematoma volume? A secondary analysis of the MISTIE-III trialPhilip Sun, Shervin Badihian, Radhika Avadhani, Nathan Walborn, Anusha Yarava, Donya Alimoradi, Issam Awad, Daniel Hanley, Santosh Murthy, Wendy Ziai
26 April 2024
Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer’s diseaseRuth Dobson, Katherine Patterson, Reshad Malik, Uttara Mandal, Hina Asif, Ros Humphreys, Michael Payne, Eng O-Charoenrat, Lauren Huzzey, Adam Clare, Kate Green, Maija Morton, Catrin Sohrabi, Navreen Singh, Amirtha PasupathySee the full list of authors
11 June 2024
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosisFrancesca Palumbo, Barbara Iazzolino, Stefano Callegaro, Antonio Canosa, Umberto Manera, Rosario Vasta, Maurizio Grassano, Enrico Matteoni, Sara Cabras, Giorgio Pellegrino, Paolina Salamone, Laura Peotta, Federico Casale, Giuseppe Fuda, Cristina MogliaSee the full list of authors
5 June 2024
Incidence and determinants of seizures in multiple sclerosis: a meta-analysis of randomised clinical trialsValeria Pozzilli, Shalom Haggiag, Massimiliano Di Filippo, Fioravante Capone, Vincenzo Di Lazzaro, Carla Tortorella, Claudio Gasperini, Luca Prosperini
21 February 2024
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriersDiane Beauvais, Céline Labeyrie, Cécile Cauquil, Bruno Francou, Ludivine Eliahou, Adeline Not, Andoni Echaniz-Laguna, Clovis Adam, Michel S Slama, Anouar Benmalek, Luca Leonardi, François Rouzet, David Adams, Vincent Algalarrondo, Guillemette Beaudonnet
24 October 2023
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)Alyssa A Toorop, Zoë YGJ van Lierop, Liza MY Gelissen, Elske Hoitsma, Esther MPE Zeinstra, Luuk C van Rooij, Caspar EP van Munster, Anke Vennegoor, Jop P Mostert, Beatrijs HA Wokke, Nynke F Kalkers, Erwin LJ Hoogervorst, Jeroen JJ van Eijk, Christiaan M Roosendaal, Jolijn J KragtSee the full list of authors
14 November 2023
Dementia prevention: the Mendelian randomisation perspectiveEmma Louise Anderson, Neil M Davies, Roxanna Korologou-Linden, Mika Kivimäki
15 November 2023
Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohortStephen A Goutman, Jonathan Boss, Dae-Gyu Jang, Bhramar Mukherjee, Rudy J Richardson, Stuart Batterman, Eva L Feldman
27 September 2023
Comparative neural correlates of DBS and MRgFUS lesioning for tremor control in essential tremorJurgen Germann, Brendan Santyr, Alexandre Boutet, Can Sarica, Clement T Chow, Gavin J B Elias, Artur Vetkas, Andrew Yang, Mojgan Hodaie, Alfonso Fasano, Suneil K Kalia, Michael L Schwartz, Andres M Lozano
18 September 2023